Ethionamide, prothionamide and thiacetazone self-administration. Studies of patient compliance using isoniazid-marked formulations.
J N
JN
Stanley
J M
JM
Pearson
G A
GA
Ellard
D000293:Adolescent; D000328:Adult; D000368:Aged; D003622:Dapsone / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D005000:Ethionamide / Q000008:administration & dosage*; D005260:Female; D006801:Humans; D007538:Isoniazid / Q000652:urine; D007539:Isonicotinic Acids / Q000008:administration & dosage*; D007918:Leprosy / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D010349:Patient Compliance; D011515:Prothionamide / Q000008:administration & dosage*; D012646:Self Administration; D013828:Thioacetazone / Q000008:administration & dosage*
D007539:Isonicotinic Acids; D011515:Prothionamide; D003622:Dapsone; D013828:Thioacetazone; D005000:Ethionamide; D007538:Isoniazid